Medicine and Dentistry
Vitamin D
100%
Supplementation
100%
Early Psychosis
63%
Psychosis
50%
Randomized Clinical Trial
50%
Neuroprotection
50%
Meta-Analysis
50%
Respiratory Disease
50%
Group Trial
50%
Systematic Review
50%
Positive and Negative Syndrome Scale
42%
Prevalence
22%
Chronic Obstructive Pulmonary Disease
22%
Global Assessment of Functioning
21%
Mental Health
20%
Patient
20%
Health Outcomes
19%
Asthma
16%
Pneumonia
16%
Association
15%
Calgary Depression Scale
15%
Follow up
14%
Mortality
11%
Population
11%
Racial Group
11%
Age
11%
Disability
11%
Ethnic Groups
11%
Symptom
11%
Vitamin D Deficiency
10%
C Reactive Protein
10%
Colecalciferol
10%
Body Mass Index
10%
Lung Tuberculosis
5%
Tuberculosis
5%
Male
5%
Therapeutic Procedure
5%
Glycated Hemoglobin
5%
Sensitivity Analysis
5%
25 Hydroxyvitamin D
5%
Adult
5%
Intention-to-Treat Analysis
5%
Population Health
5%
Health
5%
Nursing and Health Professions
Control
56%
Systematic Review
50%
Respiratory Tract Disease
50%
Meta Analysis
50%
Obstructive Lung Disease
22%
Gender
6%
Longitudinal Analysis
6%
Data Base
5%
Publication
5%
Dose
5%
Intention to Treat Analysis
5%
Cholesterol Blood Level
5%
25-Hydroxyvitamin D
5%
Glycosylated Hemoglobin
5%
Clinical Outcome
5%
Body Mass
5%
